Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd., commonly referred to as Mabworks, is a leading player in the biopharmaceutical industry, headquartered in Beijing, China. Founded in 2010, the company has rapidly established itself as a pioneer in the development of monoclonal antibodies and innovative therapeutic solutions, catering to both domestic and international markets. Mabworks focuses on the research, development, and production of high-quality biopharmaceuticals, with a particular emphasis on oncology and autoimmune diseases. Their unique approach combines advanced technology with a commitment to quality, setting them apart in a competitive landscape. Notable achievements include successful collaborations with global pharmaceutical companies and a robust pipeline of proprietary products, solidifying Mabworks' position as a trusted name in biotechnology.
DitchCarbon Score
How does Beijing Mabworks Biotech Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Mabworks Biotech Co., Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Mabworks Biotech Co., Ltd.'s reported carbon emissions
Beijing Mabworks Biotech Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Beijing Mabworks Biotech Co., Ltd. aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the biotech sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for carbon reduction. In summary, without specific emissions data or climate commitments, it is challenging to assess Beijing Mabworks Biotech Co., Ltd.'s position on carbon emissions and climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Mabworks Biotech Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
